9th International Inflammation & Immune Diseases Drug Discovery & Development Summit
|Event Date/Time: Mar 14, 2005||End Date/Time: Mar 15, 2005|
This year's conference program progresses through two full days of unique scientific presentations, the first day as a general plenary, with the second day tracked into a) inflammatory and b) immune diseases which will address key issues and complexity in finding new treatments.
The Inflammation & Immune Diseases World Summit is the largest meeting of its kind and has been organized to bring together the entire community of immunology & inflammatory researchers for the first time, as they will review many of their programs intended to generate next generation drugs.
Anti-Cytokine Therapies for Treating Human Disease
Charles A. Dinarello, M.D.
Professor of Medicine
UNIVERSITY OF COLORADO HEALTH SCIENCE CENTER
Corticosteroids - The Next Generation
Stuart Farrow, Ph.D.
Section Head, Asthma Biology, Respiratory and Inflammation Centre of Excellence
Role of B Cells in Autoimmune Diseases
Peter E. Lipsky, M.D.
Director, Intramural Research Program - Arthritis, Musculoskeletal & Skin Diseases
NATIONAL INSTITUTES OF HEALTH (NIH)
SCIENTIFIC ADVISORY BOARD:
Alan Lewis, Ph.D.
CELGENE SAN DIEGO
Brett Monia, Ph.D.
Vice President, Antisense Discovery
Martin Braddock, Ph.D.
Associate Director, Respiratory & Inflammation Research Area
James G. Karras, Ph.D.
Associate Director, Antisense Drug Discovery
Alvin F. Wells, M.D., Ph.D.
LAKESHORE MEDICAL CLINIC
Abbott Bioresearch Center
Amgen, Inc. - San Francisco (Formerly Tularik)
Amgen, Inc. - Seattle (Formerly Immunex)
AstraZeneca R&D Charnwood, UK
Biovation Ltd., UK
Celgene San Diego
Merck Research Laboratories
Pfizer Global Research & Development
Protein Design Labs
Wyeth Discovery Research
Lakeshore Medical Clinic
National Institutes of Health (NIH)
The Rayne Institute
University of Colorado Health Science Center
University of Glasgow
University of Sheffield, UK